Stay updated on Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial

Sign up to get notified when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the context of a study related to the safety, tolerability, and abuse liability of a drug called NRP104 in adults with stimulant abuse histories.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:17.000Z thumbnail image
  5. Check
    7 days ago
    No Change Detected
  6. Check
    18 days ago
    Change Detected
    Summary
    The webpage's 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying age, health conditions, and other requirements. Previously, this section only indicated that no information was provided.
    Difference
    35%
    Check dated 2024-05-22T21:02:00.000Z thumbnail image
  7. Check
    40 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:47:01.000Z thumbnail image

Stay in the know with updates to Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.